Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Vinken, Mathieu" or (type any "bookEditor journalEditor issueEditor" and editor="Vinken, ...

Add to list
- Journal Article
- A1
- open access
Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease

Eva Gijbels (UGent) , Kevin De Muynck (UGent) , Bart Vanderborght (UGent) , Tim Meese (UGent) , Filip Van Nieuwerburgh (UGent) , Aude Vanlander, Frederik Berrevoet (UGent) , Bart Hendrikx (UGent) , Anne Hoorens (UGent) , Hans Van Vlierberghe (UGent) , et al.

(2023) GENES & DISEASES. 10(1). p.18-21
Add to list
Kupffer cells contested as early drivers in the pathogenesis of primary sclerosing cholangitis

Kevin De Muynck (UGent) , Bart Vanderborght (UGent) , Federico Francesco De Ponti (UGent) , Eva Gijbels (UGent) , Sophie Van Welden (UGent) , Martin Guilliams (UGent) , Charlotte Scott (UGent) , Alain Beschin, Mathieu Vinken, Sander Lefere (UGent) , et al.

(2023) AMERICAN JOURNAL OF PATHOLOGY. 193(4). p.366-379
Add to list
- Journal Article
- A2
- open access
Dataset on transcriptomic profiling of cholestatic liver injury induced by food additives and a cosmetic ingredient

Eva Gijbels (UGent) , Lindsey Devisscher (UGent) and Mathieu Vinken

(2021) DATA IN BRIEF. 38.
Add to list
- Journal Article
- A1
- open access
Rodent models of cholestatic liver disease : a practical guide for translational research

Eva Gijbels (UGent) , Alanah Pieters, Kevin De Muynck (UGent) , Mathieu Vinken and Lindsey Devisscher (UGent)

(2021) LIVER INTERNATIONAL. 41(4). p.656-682
Add to list
- Journal Article
- A1
- open access
In vivo and in vitro models of hepatocellular carcinoma : current strategies for translational modeling

Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, Gabriel Bacil Prata, Bart Vanderborght (UGent) , Tereza Cristina da Silva, Luís Fernando Barbisan, Wellington Andraus, Lindsey Devisscher (UGent) , Niels Olsen Saraiva Câmara, et al.

(2021) CANCERS. 13(21).
Add to list
- Journal Article
- A2
- open access
Dataset on transcriptomic profiling of cholestatic liver injury in an in vitro and in vivo animal model

Eva Gijbels, Lindsey Devisscher (UGent) and Mathieu Vinken

(2020) DATA IN BRIEF. 32.
Add to list
- Journal Article
- A1
- open access
Astrocytic Connexin43 channels as candidate targets in epilepsy treatment

Laura Walrave, Mathieu Vinken, Luc Leybaert (UGent) and Ilse Smolders

(2020) BIOMOLECULES. 10(11).
Add to list
Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury

Eva Gijbels, Vânia Vilas‐Boas, Pieter Annaert, Tamara Vanhaecke, Lindsey Devisscher (UGent) and Mathieu Vinken

(2020) ARCHIVES OF TOXICOLOGY. 94(4). p.1151-1172
Add to list
Mechanisms and in vitro models of drug-induced cholestasis

Eva Gijbels, Vânia Vilas-Boas, Neel Deferm, Lindsey Devisscher (UGent) , Hartmut Jaeschke, Pieter Annaert and Mathieu Vinken

(2019) ARCHIVES OF TOXICOLOGY. 93(5). p.1169-1186
Add to list
- Journal Article
- A1
Connexin and pannexin (hemi)channels : emerging targets in the treatment of liver disease

Axelle Cooreman, Raf van Campenhout, Steven Ballet, Pieter Annaert, Bert Van Den Bossche, Isabelle Colle (UGent) , Bruno Cogliati and Mathieu Vinken

(2019) HEPATOLOGY. 69(3). p.1317-1323

Academic Bibliography

Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease

Kupffer cells contested as early drivers in the pathogenesis of primary sclerosing cholangitis

Dataset on transcriptomic profiling of cholestatic liver injury induced by food additives and a cosmetic ingredient

Rodent models of cholestatic liver disease : a practical guide for translational research

In vivo and in vitro models of hepatocellular carcinoma : current strategies for translational modeling

Dataset on transcriptomic profiling of cholestatic liver injury in an in vitro and in vivo animal model

Astrocytic Connexin43 channels as candidate targets in epilepsy treatment

Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury

Mechanisms and in vitro models of drug-induced cholestasis

Connexin and pannexin (hemi)channels : emerging targets in the treatment of liver disease

Contents

Support

Contact